268 related articles for article (PubMed ID: 28178644)
1. Clinicalpathological and prognostic significance of survivin expression in renal cell carcinoma: a meta-analysis.
Pu Z; Wang Q; Xie H; Wang G; Hao H
Oncotarget; 2017 Mar; 8(12):19825-19833. PubMed ID: 28178644
[TBL] [Abstract][Full Text] [Related]
2. Prognostic and Clinicopathological Significance of Survivin Expression in Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.
Xie Y; Ma X; Gu L; Li H; Chen L; Li X; Gao Y; Fan Y; Zhang Y; Yao Y; Zhang X
Sci Rep; 2016 Jul; 6():29794. PubMed ID: 27411378
[TBL] [Abstract][Full Text] [Related]
3. Prognostic role of survivin in renal cell carcinoma: A system review and meta-analysis.
Xiong C; Liu H; Chen Z; Yu Y; Liang C
Eur J Intern Med; 2016 Sep; 33():102-7. PubMed ID: 27350406
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological and prognostic significance of survivin expression in renal cancer patients: a meta-analysis.
Ma C; Lu B; Sun E
Postgrad Med J; 2017 Apr; 93(1098):186-192. PubMed ID: 27489375
[TBL] [Abstract][Full Text] [Related]
5. Prognostic and clinicopathological significance of PD-L1 in patients with renal cell carcinoma: a meta-analysis based on 1863 individuals.
Wang Z; Peng S; Xie H; Guo L; Cai Q; Shang Z; Jiang N; Niu Y
Clin Exp Med; 2018 May; 18(2):165-175. PubMed ID: 29362922
[TBL] [Abstract][Full Text] [Related]
6. Cancer stem cell markers predict a poor prognosis in renal cell carcinoma: a meta-analysis.
Cheng B; Yang G; Jiang R; Cheng Y; Yang H; Pei L; Qiu X
Oncotarget; 2016 Oct; 7(40):65862-65875. PubMed ID: 27588469
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological and prognostic significance of survivin expression in patients with oral squamous cell carcinoma: evidence from a meta-analysis.
Xie S; Xu H; Shan X; Liu B; Wang K; Cai Z
PLoS One; 2015; 10(2):e0116517. PubMed ID: 25710884
[TBL] [Abstract][Full Text] [Related]
8. Significance of P-glycoprotein, p53, and survivin expression in renal cell carcinoma.
Baytekin F; Tuna B; Mungan U; Aslan G; Yorukoglu K
Urol Oncol; 2011; 29(5):502-7. PubMed ID: 19945306
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Value of High CXCR4 Expression in Renal Cell Carcinoma: A System Review and Meta-Analysis.
Du Y; Long Q; Guan B; Mu L
Dis Markers; 2015; 2015():568980. PubMed ID: 26526157
[TBL] [Abstract][Full Text] [Related]
10. The prognostic value of C-reactive protein in renal cell carcinoma: a systematic review and meta-analysis.
Hu Q; Gou Y; Sun C; Ding W; Xu K; Gu B; Xia G; Ding Q
Urol Oncol; 2014 Jan; 32(1):50.e1-8. PubMed ID: 24239465
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis as a prognostic variable for the clinical outcome in patients with renal cell carcinoma: a systematic review and meta-analysis.
Zhang L; Zha Z; Qu W; Zhao H; Yuan J; Feng Y; Wu B
BMC Cancer; 2018 Sep; 18(1):870. PubMed ID: 30176824
[TBL] [Abstract][Full Text] [Related]
12. Survivin Overexpression Is Associated with Aggressive Clinicopathological Features in Cervical Carcinoma: A Meta-Analysis.
Cheng KY; Wang ZL; Gu QY; Hao M
PLoS One; 2016; 11(10):e0165117. PubMed ID: 27764228
[TBL] [Abstract][Full Text] [Related]
13. MicroRNAs as prognostic molecular signatures in renal cell carcinoma: a systematic review and meta-analysis.
Gu L; Li H; Chen L; Ma X; Gao Y; Li X; Zhang Y; Fan Y; Zhang X
Oncotarget; 2015 Oct; 6(32):32545-60. PubMed ID: 26416448
[TBL] [Abstract][Full Text] [Related]
14. C-reactive protein is a predictor of prognosis in renal cell carcinoma patients receiving tyrosine kinase inhibitors: A meta-analysis.
Wang Z; Peng S; Wang A; Xie H; Guo L; Jiang N; Niu Y
Clin Chim Acta; 2017 Dec; 475():178-187. PubMed ID: 29080691
[TBL] [Abstract][Full Text] [Related]
15. A systematic search strategy identifies cubilin as independent prognostic marker for renal cell carcinoma.
Gremel G; Djureinovic D; Niinivirta M; Laird A; Ljungqvist O; Johannesson H; Bergman J; Edqvist PH; Navani S; Khan N; Patil T; Sivertsson Å; Uhlén M; Harrison DJ; Ullenhag GJ; Stewart GD; Pontén F
BMC Cancer; 2017 Jan; 17(1):9. PubMed ID: 28052770
[TBL] [Abstract][Full Text] [Related]
16. The prognostic value of survivin expression in patients with colorectal carcinoma: a meta-analysis.
Huang YJ; Qi WX; He AN; Sun YJ; Shen Z; Yao Y
Jpn J Clin Oncol; 2013 Oct; 43(10):988-95. PubMed ID: 23894202
[TBL] [Abstract][Full Text] [Related]
17. Prognostic and clinicopathological value of PBRM1 expression in renal cell carcinoma.
Wang Z; Peng S; Guo L; Xie H; Wang A; Shang Z; Niu Y
Clin Chim Acta; 2018 Nov; 486():9-17. PubMed ID: 30006290
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of survivin in breast cancer: meta-analysis.
Li Y; Ma X; Wu X; Liu X; Liu L
Breast J; 2014; 20(5):514-24. PubMed ID: 25041354
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of carbonic anhydrase IX immunohistochemical expression in renal cell carcinoma: a meta-analysis of the literature.
Zhao Z; Liao G; Li Y; Zhou S; Zou H; Fernando S
PLoS One; 2014; 9(11):e114096. PubMed ID: 25426861
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of the Glasgow Prognostic Score in renal cell carcinoma: a meta-analysis.
Shim SR; Kim SJ; Kim SI; Cho DS
World J Urol; 2017 May; 35(5):771-780. PubMed ID: 27665441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]